Logo do repositório
 
Publicação

Is cold storage still a must? Evaluating room-temperature onabotulinumtoxinA for glabellar lines treatment

datacite.subject.fosCiências Médicas::Ciências da Saúde
datacite.subject.sdg03:Saúde de Qualidade
dc.contributor.authorRodriguez, Ruth Yimna Del Socorro Blanco
dc.contributor.authorCanales, Giancarlo De La Torre
dc.contributor.authorGiracca, César Nunes
dc.contributor.authorVaz, Thaís Caroline Schwartz Saldanha
dc.contributor.authorPaulovski, Gislaine
dc.contributor.authorMendes, Lucas Alexandre de Sousa
dc.contributor.authorCordeiro, Jairo Matozinho
dc.contributor.authorMurakami, Fábio Seigi
dc.contributor.authorCâmara-Souza, Mariana Barbosa
dc.date.accessioned2026-05-12T15:27:24Z
dc.date.available2026-05-12T15:27:24Z
dc.date.issued2025-11
dc.description.abstractBackground: New botulinum toxin type A (BoNT-A) formulations eliminated cold-chain storage before reconstitution. Nonetheless, concerns remain about BoNT-A properties when stored at room temperature after reconstitution. Aim: This study aimed to evaluate the sterility and effectiveness of BoNT-A storage at room temperature in glabellar wrinkles. Methods: BoNT-A (Allergan Botox, Brazil) was reconstituted and maintained in a stove at 37°C for 60 days and then tested for sterility according to the Pharmacopeia guidelines. Then, sixty patients aged 25–60 years were divided into two groups: Group 1 (G1) received BoNT-A immediately after reconstitution, and Group 2 (G2) received BoNT-A after 7 days at room temperature. Participants were assessed for wrinkle severity using the Merz Scale, satisfaction with treatment using the Face-Q scale, and muscle activity by electromyography. Data were collected before injections and after 15, 30, 60, and 90 days. Results: Absence of turbidity evidenced no microbial growth in all periods analyzed. Both groups showed significant reductions in glabellar contraction (p < 0.001), wrinkle severity (p < 0.05), and improved satisfaction. G1 presented lower wrinkle severity, while G2 reported higher satisfaction (p < 0.05). Conclusion: Room temperature and longer storage periods may not affect OnabotulinumtoxinA sterility and clinical results.eng
dc.identifier.citationR. Y. D. S. B.Rodriguez, G.De La Torre Canales, C. N.Giracca, et al., “Is Cold Storage Still a Must? Evaluating Room-Temperature OnabotulinumtoxinA for Glabellar Lines Treatment,” Journal of Cosmetic Dermatology, 24, no. 11 (2025): e70554, https://doi.org/10.1111/jocd.70554.
dc.identifier.doi10.1111/jocd.70554
dc.identifier.issn1473-2165
dc.identifier.urihttp://hdl.handle.net/10400.26/63090
dc.language.isoeng
dc.peerreviewedyes
dc.publisherWiley
dc.relation.hasversionhttps://doi.org/10.1111/jocd.70554
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectbotulinum toxins type A
dc.subjectreconstitution
dc.subjecttemperature
dc.titleIs cold storage still a must? Evaluating room-temperature onabotulinumtoxinA for glabellar lines treatmenteng
dc.typecontribution to journal
dspace.entity.typePublication
oaire.citation.issue11
oaire.citation.startPagee70554
oaire.citation.titleJournal of Cosmetic Dermatology
oaire.citation.volume24
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
Artigo_GDeLaTorreCanales_2025_07.pdf
Tamanho:
310.52 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.85 KB
Formato:
Item-specific license agreed upon to submission
Descrição: